Skip to main content

Table 1 Patient characteristics

From: Longitudinal microarray analysis of cell surface antigens on peripheral blood mononuclear cells from HIV+ individuals on highly active antiretroviral therapy

Parameter

Group

Baseline

Time point 2

Time point 3

Time point 4

CD4 countsc

SRa

820 (800–1050)

880 (800–960)

1050 (978–1228)

1000 (825–1145)

 

TRb

560 (480–720)

705 (588–887)

673 (557–835)

782 (627–903)

CD8 countsc

SRa

950 (780–1140)

1029 (828–1175)

824 (705–960)

890 (675–992)

 

TRb

1200 (1040–1300)

915 (819–979)

969 (880–1062)

918 (862–967)

Viral loadd

SRa

3 BDL (169841–750000)

4 BDL (624, 931)

5 BDL (810)

6 BDL

 

TRb

3 BDL (2500–58292)

4 BDL (1340, 95280)

3 BDL (1300–8146)

1 BDL (390–180991)

  1. a SR: sustained responder group.
  2. b TR: transient responder group.
  3. c CD4 and CD8 counts were median (first quartile-third quartile), expressed as cell numbers per μl blood.
  4. d Viral load shows the number of patients with below detectable level (BDL) of virus; also shown, in brackets, are the HIV-1 copy numbers/ml for the viremic patients, with a range of the HIV-1 copy numbers shown for groups with more than 2 viremic patients.